Author Reflects on Healing Power of Faith in Debut Memoir
November 16, 2020 07:00 ET
|
WestBow Press
BROKEN ARROW, Okla., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Author Darrell Hazle has published his debut memoir, which twines his experiences growing in his faith and relationship with God with an...
OWP Pharmaceuticals Announces IND Approval for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
October 07, 2020 08:00 ET
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Oct. 07, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Peer Specialist Chronicles His Epic Faith Journey and Experiences With Bipolar Disorder in Uplifting Collection of Poetry and Prose
July 20, 2020 07:00 ET
|
AuthorHouse
MILWAUKEE, July 20, 2020 (GLOBE NEWSWIRE) -- Making sense of a world that often makes no sense at all is one of life’s greatest challenges. In his book “55 Reflections of a Searching Skeptic:...
Author Reflects on Inspiring Journey of Spiritual Growth, Shares Experiences Healing from Bipolar Disorder in Debut Memoir
July 13, 2020 08:00 ET
|
XlibrisUS
NAPLES, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Author Bárbaro Baez Alvarez has published his debut, inspirational self-help memoir that twines his journey of spiritual growth with his experiences...
OWP Pharmaceuticals Announces Pre-IND Acknowledgement and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
January 08, 2020 08:00 ET
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder
December 03, 2019 08:00 ET
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Dec. 03, 2019 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Neuroleptics Market To Reach USD 15.41 Billion By 2026 | Reports And Data
April 15, 2019 12:39 ET
|
Reports And Data
Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future. Market...